RobertCQuackenbushMD

PubMed

• 50 citations
  Neutrophilic-chronic myeloid leukemia: Low levels of p230 BCR/ABL mRNA and undetectable p230 BCR/ABL protein may predict an indolent course
  Srdan Verstovsek, Hui Lin, Hagop Kantarjian, Giuseppe Saglio, Daniela De Micheli, Fabrizio Pane, Guillermo Garcia-Manero, Mariano Intrieri, Bruno Rotoli, Francesco Sal...> ;Cancer. 2002 May 1
• 43 citations
  Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases.
  Robert C. Quackenbush, Gary W. Reuther, Juli P. Miller, Kevin D. Courtney, Warren S. Pear, Ann Marie Pendergast> ;Blood. 2000 May 1
• 611 citations
  Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow
  Warren S. Pear, Juli P. Miller, Lanwei Xu, John C. Pui, Benny Soffer, Robert C. Quackenbush, Ann Marie Pendergast, Roderick T. Bronson, Jon C. Aster, Martin L. Scott, ...> ;Blood. 1998 Nov 15
• 91 citations
  Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway
  Zonghan Dai, Robert C. Quackenbush, Kevin D. Courtney, Matthew Grove, David Cortez, Gary W. Reuther, Ann Marie Pendergast> ;Genes & Development. 1998 May 15
• Join now to see all